Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 4
1971 1
1978 1
1979 1
1980 1
1981 1
1982 7
1984 5
1986 5
1987 3
1988 3
1989 1
1990 1
1991 4
1992 1
1993 3
1995 2
1996 3
1997 2
1998 2
1999 5
2000 1
2001 3
2002 2
2004 3
2005 2
2006 2
2007 2
2008 2
2009 1
2010 5
2011 5
2012 13
2013 16
2014 15
2015 17
2016 20
2017 22
2018 23
2019 19
2020 16
2021 15
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

245 results
Results by year
Filters applied: . Clear all
Page 1
Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD.
Wedzicha JA, Banerji D, Chapman KR, Vestbo J, Roche N, Ayers RT, Thach C, Fogel R, Patalano F, Vogelmeier CF; FLAME Investigators. Wedzicha JA, et al. N Engl J Med. 2016 Jun 9;374(23):2222-34. doi: 10.1056/NEJMoa1516385. Epub 2016 May 15. N Engl J Med. 2016. PMID: 27181606 Free article. Clinical Trial.
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.
Rabe KF, Martinez FJ, Ferguson GT, Wang C, Singh D, Wedzicha JA, Trivedi R, St Rose E, Ballal S, McLaren J, Darken P, Aurivillius M, Reisner C, Dorinsky P; ETHOS Investigators. Rabe KF, et al. N Engl J Med. 2020 Jul 2;383(1):35-48. doi: 10.1056/NEJMoa1916046. Epub 2020 Jun 24. N Engl J Med. 2020. PMID: 32579807 Clinical Trial.
▾Glycopyrronium for COPD.
[No authors listed] [No authors listed] Drug Ther Bull. 2013 Jun;51(6):66-8. doi: 10.1136/dtb.2013.6.0184. Epub 2013 Jun 6. Drug Ther Bull. 2013. PMID: 23744364 Review.
245 results